Bacterial Glycolipids and Analogs As Antigens for CD1d-restricted NKT Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2005 Jan 25

PMID 15665086

Citations 95

Authors

Douglass Wu

Guo-Wen Xing

Michael A Poles

Amir Horowitz

Yuki Kinjo

Barbara Sullivan

Vera Bodmer-Narkevitch

Oliver Plettenburg

Mitchell Kronenberg

Moriya Tsuji

David D Ho

Chi-Huey Wong

Affiliations

Soon will be listed here.

Abstract

The CD1 family of proteins binds self and foreign glycolipids for presentation to CD1-restricted T cells. To identify previously uncharacterized active CD1 ligands, especially those of microbial origin, numerous glycolipids were synthesized and tested for their ability to stimulate mouse and human natural killer T (NKT) cells. They included analogs of the well known NKT cell agonist alpha-galactosyl ceramide (alpha-GalCer), bacterial glycolipids, and variations of the self-glycolipid, sulfatide. Bacterial glycolipids, alpha-galacturonosyl-ceramides from Sphingomonas wittichii, although structurally similar to alpha-GalCer, have significant differences in the sugar head group as well as the ceramide portion. The Sphingomonas glycosphingolipids (GSLs) and sulfatide variants were shown to activate human NKT cells as measured by IL-4 and IFN-gamma secretion. Moreover, CD1d-dimer staining revealed human NKT cell reactivity toward these GSLs and to the sulfatides in a fashion comparable with alpha-GalCer. Because alpha-GalCer is a marine-sponge-derived ligand, our study here shows that bacterium-derived antigens are also able to stimulate mouse and human NKT cells.

Citing Articles

Role of innate T cells in necrotizing enterocolitis.

Liu J, Joseph S, Manohar K, Lee J, Brokaw J, Shelley W Front Immunol. 2024; 15:1357483.

PMID: 38390341 PMC: 10881895. DOI: 10.3389/fimmu.2024.1357483.

Lysosomal processing of sulfatide analogs alters target NKT cell specificity and immune responses in cancer.

Nishio K, Pasquet L, Camara K, DiSapio J, Hsu K, Kato S J Clin Invest. 2023; 134(4).

PMID: 38127463 PMC: 10866642. DOI: 10.1172/JCI165281.

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity.

Liu S, Wang W, Hu S, Jia B, Tuo B, Sun H Cell Death Dis. 2023; 14(10):679.

PMID: 37833255 PMC: 10575861. DOI: 10.1038/s41419-023-06211-2.

Gut Microbiota-Derived Unconventional T Cell Ligands: Contribution to Host Immune Modulation.

Oh S, Jung D, Choi E Immunohorizons. 2022; 6(7):476-487.

PMID: 35868838 PMC: 9924074. DOI: 10.4049/immunohorizons.2200006.

Chemical Synthesis of Cell Wall Constituents of .

Holzheimer M, Buter J, Minnaard A Chem Rev. 2021; 121(15):9554-9643.

PMID: 34190544 PMC: 8361437. DOI: 10.1021/acs.chemrev.1c00043.

References

Elewaut D, Lawton A, Nagarajan N, Maverakis E, Khurana A, Honing S . The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells. J Exp Med. 2003; 198(8):1133-46. PMC: 2194227. DOI: 10.1084/jem.20030143. View

Porcelli S, Modlin R . The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol. 1999; 17:297-329. DOI: 10.1146/annurev.immunol.17.1.297. View

Singh N, Hong S, Scherer D, Serizawa I, Burdin N, Kronenberg M . Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol. 1999; 163(5):2373-7. View

Zajonc D, Elsliger M, Teyton L, Wilson I . Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. Nat Immunol. 2003; 4(8):808-15. DOI: 10.1038/ni948. View

Goff R, Gao Y, Mattner J, Zhou D, Yin N, Cantu 3rd C . Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells. J Am Chem Soc. 2004; 126(42):13602-3. DOI: 10.1021/ja045385q. View

Joyce S, Van Kaer L . CD1-restricted antigen presentation: an oily matter. Curr Opin Immunol. 2002; 15(1):95-104. DOI: 10.1016/s0952-7915(02)00012-2. View

Burdin N, Brossay L, Kronenberg M . Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol. 1999; 29(6):2014-25. DOI: 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G. View

Plettenburg O, Bodmer-Narkevitch V, Wong C . Synthesis of alpha-galactosyl ceramide, a potent immunostimulatory agent. J Org Chem. 2002; 67(13):4559-64. DOI: 10.1021/jo0201530. View

Deng S, Yu B, Lou Y, Hui Y . First Total Synthesis of an Exceptionally Potent Antitumor Saponin, OSW-1. J Org Chem. 2001; 64(1):202-208. DOI: 10.1021/jo981685c. View

10.

Kronenberg M, Gapin L . The unconventional lifestyle of NKT cells. Nat Rev Immunol. 2002; 2(8):557-68. DOI: 10.1038/nri854. View

11.

Hong S, Wilson M, Serizawa I, Wu L, Singh N, Naidenko O . The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med. 2001; 7(9):1052-6. DOI: 10.1038/nm0901-1052. View

12.

Ben-Menachem G, Kubler-Kielb J, Coxon B, Yergey A, Schneerson R . A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proc Natl Acad Sci U S A. 2003; 100(13):7913-8. PMC: 164687. DOI: 10.1073/pnas.1232451100. View

13.

Yang G, Schmieg J, Tsuji M, Franck R . The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): synthesis and striking enhancement of activity. Angew Chem Int Ed Engl. 2004; 43(29):3818-22. DOI: 10.1002/anie.200454215. View

14.

Batuwangala T, Shepherd D, Gadola S, Gibson K, Zaccai N, Fersht A . The crystal structure of human CD1b with a bound bacterial glycolipid. J Immunol. 2004; 172(4):2382-8. DOI: 10.4049/jimmunol.172.4.2382. View

15.

Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P . CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med. 1998; 188(8):1521-8. PMC: 2213408. DOI: 10.1084/jem.188.8.1521. View

16.

Kawahara K, Kubota M, Sato N, Tsuge K, Seto Y . Occurrence of an alpha-galacturonosyl-ceramide in the dioxin-degrading bacterium Sphingomonas wittichii. FEMS Microbiol Lett. 2002; 214(2):289-294. DOI: 10.1111/j.1574-6968.2002.tb11361.x. View

17.

Wu D, Segal N, Sidobre S, Kronenberg M, Chapman P . Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med. 2003; 198(1):173-81. PMC: 2196074. DOI: 10.1084/jem.20030446. View

18.

Brossay L, Naidenko O, Burdin N, Matsuda J, Sakai T, Kronenberg M . Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J Immunol. 1998; 161(10):5124-8. View

19.

Sidobre S, Hammond K, Benazet-Sidobre L, Maltsev S, Richardson S, Ndonye R . The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc Natl Acad Sci U S A. 2004; 101(33):12254-9. PMC: 514465. DOI: 10.1073/pnas.0404632101. View

20.

Calabi F, Jarvis J, Martin L, Milstein C . Two classes of CD1 genes. Eur J Immunol. 1989; 19(2):285-92. DOI: 10.1002/eji.1830190211. View